Scientists show drug may greatly improve cancer immunotherapy success

(University of Southampton) A study led by the University of Southampton, funded by Cancer Research UK, has shown a new drug -- originally developed to tackle the scarring of organ tissue -- could help to significantly improve the success rate of cancer immunotherapy treatment.